The basic criteria for the system’s success *By Kyriakos Mikellis The provision of healthcare services to Cypriot citizens through the implementation of a functional, efficient and sustainable health system is something that should have happened many years ago. The...
Paves the way to improve patients’ access to innovative medicines The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) welcomes the vote on the NHS bill by the House of Representatives Plenum. This is an important moment for the Republic...
NHS and falsified medicines top priorities of new Board Kyriakos Mikellis, Cyprus Business Manager at Pfizer, has been re-elected president of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) for another two year term. In statements,...
KEFEA: Aim is to boost credibility at European level Transfers of value made by pharmaceutical companies involving the expenses incurred in relation to healthcare professionals and healthcare organisations are to be made public for the first time by the end of June as...
* By Kyriakos Mikellis In most European countries, unlike Cyprus, policies on pharmaceuticals give patients access to the treatment their doctors consider the most appropriate. Pharmaceuticals and pharmaceutical care are usually the responsibility of three independent...
